Skip to content

An interventional clinical study of comparative effect of Durva and Gandhak ointment in the selected participants of eczema

A comparative clinical study of Durva Malahara and Gandhakadya Malahara in the management of Eczema - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068584
Enrollment
30
Registered
2024-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20-L30- Dermatitis and eczema

Interventions

None listed

Sponsors

Dr Bansi Monpara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients between age group of 16-60 years. 2) Patients having minimum 3-4 signs and symptoms of eczema fulfilling the diagnosis.

Exclusion criteria

Exclusion criteria: 1) Patients having any other diseases like AIDS, STD, TB, DM and other disorders which lead to fatal condition for the patients. 2) Pregnant and lactating women. 3) Patients who are on corticosteroid drugs or immune-suppressants and past history of steroidal use in the last 6 months. 4) Other concomitant skin disease occurring with allergic reaction of any other disease.

Design outcomes

Primary

MeasureTime frame
Changes in itching, discolouration, crusting, dryness, scaling, burning sensationTimepoint: Before and after the intervention of trial drug

Secondary

MeasureTime frame
Changes in EASI scoreTimepoint: Before and after the intervention of trial drug

Countries

India

Contacts

Public ContactDr Bansi B Monpara

Maganbhai Adenwala Mahagujarat University

rejukrishnanr50@gmail.com9066030409

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026